Technology Partner: Genomenon

Genomenon Mastermind and CKB, inside VarSeq

Pull Genomenon's Mastermind literature evidence into VarSeq variant interpretation. Curated gene-disease and variant-disease associations enhance your analysis and support confident clinical decisions.

27M+ Indexed Variants
ACMG/AMP Aligned Curation

Pathogenicity classification leans on prior literature. As papers accumulate faster than any analyst can read them, a curated, variant-indexed genomic literature database is what keeps the evidence step at minutes per case instead of hours.

Golden Helix loads Genomenon’s Mastermind and Cancer Knowledgebase (CKB) as annotation sources inside VarSeq. Variant literature evidence and curated variant database calls sit on the same row as ClinVar, gnomAD, and OMIM, with no second tab to open.

Rare-disease teams and oncology teams use the same VarSeq project: Mastermind covers variant-disease and gene-disease association evidence for ACMG review, and CKB covers somatic therapy, trial, and resistance evidence for AMP review.

Mastermind Genomic Intelligence

Genomenon combines AI-assisted curation with expert review to index over 27 million variants across the global literature. Clinical labs and pharma teams use Mastermind to drive ACMG and AMP variant interpretation against peer-reviewed evidence rather than a single PubMed sweep per case.

  • Coverage: 27M+ variants indexed against the global literature, including findings that have not yet reached ClinVar.
  • Evidence on the row: Each variant carries direct links to the supporting publications for pathogenicity, phenotype, and diagnostic-criteria claims.
  • Defensible classifications: Genomenon's calls sit next to ClinVar and gnomAD in the same VarSeq view, so the rationale travels with the report.

Genomenon Cancer Knowledgebase

The Cancer Knowledgebase (CKB) offers oncology-specific curation, linking variants to therapies, trials, and prognostic relevance.

  • Actionable Oncology: Quickly identify targeted therapies and relevant clinical trials for somatic findings.
  • Precision Medicine: Connect genomic alterations directly to FDA-approved therapies and companion diagnostics.
  • Expert Curation: Genomenon's oncology curators update CKB as new therapies, trials, and resistance markers publish.

Benefits of Premium Curated Evidence

Faster Turnaround

Cut the manual literature-search step out of variant review. Every variant in VarSeq carries its Mastermind evidence in the same view as filter-chain output.

Diagnostic Yield

Mastermind catches pathogenic variants that haven't reached ClinVar yet, so candidate lists stay short without dropping real findings.

Regulatory Compliance

Each classification carries its evidence and curator action history in one place.

Somatic Decision Support

Link somatic variants to therapies, trials, and evidence to inform oncology diagnosis and treatment decisions.

Scales with Volume

The same annotation runs on a single case or a full week's batch. Mastermind and CKB lookups happen at import, not at review time.

Germline and Somatic in One Project

Mastermind covers germline literature, CKB covers oncology therapy and trial evidence. Both annotate the same VarSeq project.

Integration Detail

Mastermind and CKB in the VarSeq annotation pass

Mastermind and CKB load as VarSeq annotation sources alongside ClinVar, gnomAD, and OMIM. Filter chains can reference Mastermind article counts and CKB therapy levels directly, so curated literature shapes prioritization, not just final review.

In-Platform Literature

Search and review literature-backed variant data without leaving your analysis software.

ACMG/AMP Evidence

Mastermind and CKB classifications feed VSClinical's ACMG and AMP scoring rules, so the curator's call shows up next to the rule it informs.

Defensible Reports

Generate evidence-supported clinical reports with direct citations to curated literature.

"By integrating Genomenon's Mastermind directly into VarSeq, we've reduced manual literature review time by over 70% while improving our diagnostic yield."

Clinical Laboratory User

Clinical Workflows

Hereditary & Rare Disease

Leverage Mastermind for expert curated classifications and ACMG criteria. Accelerate rare disease diagnosis with instant evidence for candidate variants.

Rare Disease Solutions

Precision Oncology

Use CKB to connect somatic variants with therapies, clinical trials, and literature evidence. Identify targeted treatment strategies rapidly.

Oncology Workflows

Variant Prioritization

Integrate curated evidence into filtering strategies to focus only on variants with existing clinical or functional relevance.

Variant Analysis Details

Frequently Asked Questions

What is included in the Mastermind database?

Mastermind indexes over 27 million germline and somatic variants, providing deep insights into pathogenicity, gene-disease relationships, and phenotypic associations derived from global literature.

How is CKB different from Mastermind?

While Mastermind focuses on comprehensive variant-literature evidence, the Cancer Knowledgebase (CKB) is specifically curated for oncology, linking somatic variants directly to therapies, trials, and diagnostic criteria.

Does this integration require an additional subscription?

Yes, the Genomenon Mastermind and CKB integrations are available as premium annotation modules within the VarSeq Suite. Contact our sales team for licensing details.

How often are the databases updated?

Genomenon updates their curated content regularly to include the most recent peer-reviewed publications and clinical trial updates, which are then synced directly into VarSeq.

Evidence & Interpretation Insights

Learn how to leverage expert curated literature to accelerate your clinical interpretation workflows.

See Mastermind and CKB run in your VarSeq

Talk to our team about turning on Mastermind and CKB inside your VarSeq install.

27M+ Indexed Variants
ACMG/AMP Aligned Curation
Therapy & Trial Matching